Trafficking of tachykinin neurokinin 3 receptor to nuclei of neurons in the paraventricular nucleus of the hypothalamus following osmotic challenge

Neuroscience

Volumn 155, Issue 1, 2008, Pages 308-316

  Jensen, D ^a   Zhang, Z ^a   Flynn, F W ^a  

^a UNIVERSITY OF WYOMING   (United States)

Author keywords

cell signaling; electron microscopy; G protein coupled receptor; siRNA

Indexed keywords

NEUROKININ 3 RECEPTOR; SMALL INTERFERING RNA; SODIUM CHLORIDE; TACHYKININ;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; HYPOTHALAMUS; IMMUNOELECTRON MICROSCOPY; IMMUNOREACTIVITY; MALE; NONHUMAN; OSMOSIS; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS; WESTERN BLOTTING;

ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 1; CELL NUCLEUS; GENE EXPRESSION REGULATION; MALE; MEMBRANE PROTEINS; MICROSCOPY, ELECTRON, TRANSMISSION; NEURONS; OSMOSIS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PROTEIN TRANSPORT; RATS; RECEPTORS, NEUROKININ-3; RNA, SMALL INTERFERING; TIME FACTORS;

EID: 48949115252     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.05.024     Document Type: Article

References (51)

1. Ackley M.A., Asghar A.U.R., Worsley M.A., and King A.E. Peripheral inflammation reduces the response of spinal dorsal horn neurons to an NK3 receptor agonist. Neurosci Lett 308 (2001) 13-16
2. Armstrong W.E., Gregory W.A., and Hatton G.I. Nucleolar proliferation and cell size changes in rat supraoptic neurons following osmotic and volemic challenges. Brain Res Bull 2 (1977) 7-14
3. Bealer S.L., and Flynn F.W. Central neurokinin 3 receptors increase systemic oxytocin release: interaction with norepinephrine. Exp Neurol 184 (2003) 1027-1033
4. Berciano M.T., Villagra N.T., Pena E., Navascues J., Casafont I., and Lafarga M. Structural and functional compartmentalization of the cell nucleus in supraoptic neurons. Microsc Res Tech 56 (2002) 132-142
5. Bkaily G., Sleiman S., Stephan J., Asselin C., Choufani S., Kamal M., Jacques D., Gobeil Jr. F., and Orleans-Juste P. Angiotensin II AT1 receptor internalization, translocation and de novo synthesis modulate cytosolic and nuclear calcium in human vascular smooth muscle cells. Can J Physiol Pharmacol 81 (2003) 274-287
6. Briggs L.J., Stein D., Goltz J., Corrigan V.C., Efthymiadis A., Hubner S., and Jans D.A. The cAMP-dependent protein kinase site (Ser312) enhances dorsal nuclear import through facilitating nuclear localization sequence/importin interaction. J Biol Chem 273 (1998) 22745-22752
7. Buell G., Schulz M.F., Arkinstall S.J., Maury K., Missotten M., Adami N., Talabot F., and Kawashima E. Molecular characterisation, expression and localisation of human neurokinin-3 receptor. FEBS Lett 299 (1992) 90-95
8. Burry R.W. Specificity controls for immunocytochemical methods. J Histochem Cytochem 48 (2000) 163-166
9. Chawala M., Gutierrez G., Young III W., McMullen N., and Rance N. Localization of neurons expressing substance P and neurokinin B gene transcripts in the human hypothalamus and basal forebrain. J Comp Neurol 384 (1997) 429-442
10. Colin I., Blondeau C., and Baude A. Neurokinin release in the rat nucleus of the solitary tract via NMDA and AMPA receptors. Neuroscience 115 (2002) 1023-1033
11. Ding Y.Q., Shigemoto R., Takada M., Ohishi H., Nakanishi S., and Mizuno N. Localization of the neuromedin K receptor (NK3) in the central nervous system of the rat. J Comp Neurol 364 (1996) 290-310
12. Ding Y.-Q., Lu B.-Z., Guan Z.-L., Wang D.-S., Xu J.-Q., and Li J.-H. Neurokinin B receptor (NK3)-containing neurons in the paraventricular and supraoptic nuclei of the rat hypothalamus synthesize vasopressin and express Fos following intravenous injection of hypertonic saline. Neuroscience 91 (1999) 1077-1085
13. Ding Y., and Lawrence C.E. Rational design of siRNAs with the Sfold software. In: Krishnarao A. (Ed). RNA interference technology (2005), Cambridge University Press, New York 129-138
14. Fox A.H., Lam Y.W., Leung A.K., Lyon C.E., Andersen J., Mann M., and Lamond A.I. Paraspeckles: a novel nuclear domain. Curr Biol 12 (2002) 13-25
15. Ghorbel M.T., Sharman G., Hindmarch C., Becker K.G., Barrett T., and Murphy D. Microarray screening of suppression subtractive hybridization-PCR cDNA libraries identifies novel RNAs regulated by dehydration in the rat supraoptic nucleus. Physiol Genomics 24 (2006) 163-172
16. Glasgow E., Murase T., Zhang B., Verbalis J.G., and Gainer H. Gene expression in the rat supraoptic nucleus induced by chronic hyperosmolality versus hyposmolality. Am J Physiol Regul Integr Comp Physiol 279 (2000) R1239-R1250
17. Haley G.E., and Flynn F.W. Tachykinin NK3 receptor contribution to systemic release of vasopressin and oxytocin in response to osmotic and hypotensive challenge. Am J Physiol Regul Integr Comp Physiol 293 (2007) R931-R937
18. Haley G.E., and Flynn F.W. Agonist and hypertonic saline-induced trafficking of the NK3-receptors on vasopressin neurons within the paraventricular nucleus of the hypothalamus. Am J Physiol Regul Integr Comp Physiol 290 (2006) R1242-R1250
19. Hamada M., Ohtsuka T., Kawaida R., Koizumi M., Morita K., Furukawa H., Imanishi T., Miyagishi M., and Taira K. Effects on RNA interference in gene expression (RNAi) in cultured mammalian cells of mismatches and the introduction of chemical modifications at the 3′-ends of siRNAs. Antisense Nucleic Acid Drug Dev 12 (2002) 301-309
20. Henkel T., Zabel U., van Zee K., Muller J.M., Fanning E., and Baeuerle P.A. Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-[kappa]B subunit. Cell 68 (1992) 1121-1133
21. Howe H.E., Somponpun S.J., and Sladek C.D. Role of neurokinin 3 receptors in supraoptic vasopressin and oxytocin neurons. J Neurosci 24 (2004) 10103-10110
22. Hubbard C., Singleton D., Rauch M., Jayasinghe S., Cafiso D., and Castle D. The secretory carrier membrane protein family: structure and membrane topology. Mol Biol Cell 11 (2000) 2933-2947
23. Jackson A.L., Burchard J., Leake D., Reynolds A., Schelter J., Guo J., Johnson J.M., Lim L., Karpilow J., Nichols K., Marshall W., Khvorova A., and Linsley P.S. Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing. RNA 12 (2006) 1197-1205
24. Jans D.A., and Hassan G. Nuclear targeting by growth factors, cytokines, and their receptors: a role in signaling?. Bioessays 20 (1998) 400-411
25. Jans D.A., Xiao C.Y., and Lam M.H. Nuclear targeting signal recognition: a key control point in nuclear transport?. Bioessays 22 (2000) 532-544
26. Johnson H.M., Subramaniam P.S., Olsnes S., and Jans D.A. Trafficking and signaling pathways of nuclear localizing protein ligands and their receptors. Bioessays 26 (2004) 993-1004
27. Kawasaki M., Yamaguchi K., Saito J., Ozaki Y., Mera T., Hashimoto H., Fujihara H., Okimoto N., Ohnishi H., Nakamura T., and Ueta Y. Expression of immediate early genes and vasopressin heteronuclear RNA in the paraventricular and supraoptic nuclei of rats after acute osmotic stimulus. J Neuroendocrinol 17 (2005) 227-237
28. Lee D.K., Lanca A.J., Cheng R., Nguyen T., Ji X.D., Gobeil Jr. F., Chemtob S., George S.R., and O'Dowd B.F. Agonist-independent nuclear localization of the apelin, angiotensin AT1, and bradykinin B2 receptors. J Biol Chem 279 (2004) 7901-7908
29. Lessard A., Laurin M., Yamaguchi N., and Couture R. Central anti-hypertensive effect of tachykinin NK3 receptor antagonists in rat. Eur J Pharmacol 486 (2004) 75-83
30. Mantyh P.W., Allen C.J., Ghilardi J.R., Rogers S.D., Mantyh C.R., Liu H., Basbaum A.I., Vigna S.R., and Maggio J.E. Rapid endocytosis of a G protein-coupled receptor: substance P evoked internalization of its receptor in the rat striatum in vivo. Proc Natl Acad Sci U S A 92 (1995) 2622-2626
31. Meister B., Cortes R., Villar M.J., Schalling M., and Hokfelt T. Peptides and transmitter enzymes in hypothalamic magnocellular neurons after administration of hyperosmotic stimuli: comparison between messenger RNA and peptide/protein levels. Cell Tissue Res 260 (1990) 279-297
32. Mileusnic D., Lee J.M., Magnuson D.J., Hejna M.J., Krause J.E., Lorens J.B., and Lorens S.A. Neurokinin-3 receptor distribution in rat and human brain: an immunohistochemical study. Neuroscience 89 (1999) 1269-1290
33. Morinelli T.A., Raymond J.R., Baldys A., Yang Q., Lee M.H., Luttrell L., and Ullian M.E. Identification of a putative nuclear localization sequence within ANG II AT(1A) receptor associated with nuclear activation. Am J Physiol Cell Physiol 292 (2007) C1398-C1408
34. Moroianu J. Nuclear import and export pathways. J Cell Biochem Suppl 32- 33 (1999) 76-83
35. Naruse M., Naruse K., Mckenzie J.C., Schelling P., and Inagami T. Regional distribution of renin and angiotensinogen in the brain of normotensive (Wky) and spontaneously hypertensive (Shr) rats. Brain Res 333 (1985) 147-150
36. Nigg E.A. Nucleocytoplasmic transport: signals, mechanisms and regulation. Nature 386 (1997) 779-787
37. Overton M.C., and Blumer K.J. G-protein-coupled receptors function as oligomers in vivo. Curr Biol 10 (2000) 341-344
38. Panocka I., Massi M., Lapo I., Swiderski T., Kowalczyk M., and Sadowski B. Antidepressant-type effect of the NK3 tachykinin receptor agonist aminosenktide in mouse lines differing in endogenous opioid system activity. Peptides 22 (2001) 1037-1042
39. Phair R.D., and Misteli T. High mobility of proteins in the mammalian cell nucleus. Nature 404 (2000) 604-609
40. Pickard B.W., Hodsman A.B., Fraher L.J., and Watson P.H. Type 1 parathyroid hormone receptor (PTH1R) nuclear trafficking: regulation of PTH1R nuclear-cytoplasmic shuttling by importin-{alpha}/{beta} and chromosomal region maintenance 1/exportin 1. Endocrinology 148 (2007) 2282-2289
41. Saavedra J.M., Israel A., Plunkett L.M., Kurihara M., Shigematsu K., and Correa F.M. Quantitative distribution of angiotensin II binding sites in rat brain by autoradiography. Peptides 7 (1986) 679-687
42. Sacco-Bubulya P., and Spector D.L. Disassembly of interchromatin granule clusters alters the coordination of transcription and pre-mRNA splicing. J Cell Biol 156 (2002) 425-436
43. Salome N., Stemmelin J., Cohen C., and Griebel G. Selective blockade of NK2 or NK3 receptors produces anxiolytic- and antidepressant-like effects in gerbils. Pharmacol Biochem Behav 83 (2006) 533-539
44. Savory J.G., Hsu B., Laquian I.R., Giffin W., Reich T., Hache R.J., and Lefebvre Y.A. Discrimination between NL1- and NL2-mediated nuclear localization of the glucocorticoid receptor. Mol Cell Biol 19 (1999) 1025-1037
45. Schmidlin F., Roosterman D., and Bunnett N.W. The third intracellular loop and carboxyl tail of neurokinin 1 and 3 receptors determine interactions with {beta}-arrestins. Am J Physiol Cell Physiol 285 (2003) C945-C958
46. Schwarz D.S., Ding H., Kennington L., Moore J.T., Schelter J., Burchard J., Linsley P.S., Aronin N., Xu Z., and Zamore P.D. Designing siRNA that distinguish between genes that differ by a single nucleotide. PLoS Genet 2 (2006) e140
47. Smith M.E., and Flynn F.W. Distribution of Fos-like immunoreactivity within the rat brain following intraventricular injection of the selective NK(3) receptor agonist senktide. J Comp Neurol 426 (2000) 413-428
48. Subramaniam P.S., Torres B.A., and Johnson H.M. So many ligands, so few transcription factors: a new paradigm for signaling through the STAT transcription factors. Cytokine 15 (2001) 175-187
49. Swaab D.F., Pool C.W., and Van Leeuwen F.W. Can specificity ever be proved in immunocytochemical staining [letter]?. J Histochem Cytochem 25 (1977) 388-391
50. Thevenin D., Lazarova T., Roberts M.F., and Robinson C.R. Oligomerization of the fifth transmembrane domain from the adenosine A2A receptor. Protein Sci 14 (2005) 2177-2186
51. Yang H., Lu D., Vinson G.P., and Raizada M.K. Involvement of MAP kinase in angiotensin II-induced phosphorylation and intracellular targeting of neuronal AT1 receptors. J Neurosci 17 (1997) 1660-1669